loading…
PT Natura Nuswantara Nirmala (Nucleus Farma) is one of the leading bio-tech company which is an innovative producer of natural medicines and health supplements. This company uses local natural ingredients native to Indonesia.
Recently, Nucleus Farma has successfully conducted research by proving that Onoiwa MX products are effective as standard adjuvants for Covid-19 treatment for early-stage patients. This research is included in an international medical journal in Europe so that it has been published in the European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 2945-2957 in July 2021. It has also passed the ethical test in accordance with the standards of the Code of Ethics of the World Medical Association-Declaration of Helsinksi.
The research involved a number of researchers and practitioners who are experts in their fields. He includes Prof. Dr. apt. Syamsudin, M. Biomed (Professor of Pharmacology of Natural Materials from the Faculty of Pharmacy, Pancasila University), dr. Lusi Nursilawati Syamsi, Sp. (practitioner lung specialist who treats Covid-19), Dr.rer.nat. Chairir Amin from BPPT and Dr. Nurita Andayani, statistician.
Also read: Call of Duty Cold War New Season Arrivals New Game Mode
“It is a very proud achievement, an original Indonesian product, produced by Nucleus Farma, to be included in research studies in articles from international journals,” said Edward Basilianus, CEO of Nucleus Farma, in his statement, Sunday (11/7/2021).
– .
